Gilead Ties Up With Generic Drugmakers in India, Pak for Supply of Potential Covid-19 Drug Remdesivir in Top Business News- News18.com published on May 12, 2020 leave a reply With no other approved treatment for COVID-19, the respiratory illness caused by the novel coronavirus, interest in remdesivir has been growing. from Top Business News- News18.com https://ift.tt/35TsjI0 Tweet Share Share Share Share Previous Post Sensex Zooms Over 1,400 Points After PM Modi's Rs 20L Crore Economic Booster Amid Covid-19 Next Post Indian lenders Pitch for Govt-funded 'Bad Bank' Due to Covid-19 Crisis, Say Sources post written by: Rohit Related PostsOil Falls 1% On Lacklustre Demand, Set For Biggest Weekly Drop Since JuneOil futures slipped 1% on Friday, with prices on both sides of the Atlantic heading for their biggest weekly drops since June, as lacklustre demand and ample fu… Continue ReadingVirgin Australia Creditors Approve Airline's Purchase By Bain Capital - UnionVirgin Australia Holdings Ltd's creditors on Friday voted in favour of the purchase of Australia's secondbiggest airline by U.S. private equity group Bain Capit… Continue ReadingWhite House Says It Does Not Expect U.S. Government Shutdown At Month's EndThe White House on Thursday said it expects Congress to approve the legislation needed to avoid a government shutdown at the end of the month, when current spen… Continue ReadingAsian Stocks Slip After Wall Street Selloff Dents Tech RallyAsia's stock markets had their worst session in two weeks on Friday following a techled plunge on Wall Street, though gains in safer assets like bonds and dolla… Continue ReadingYum China To Raise $2.2 Billion In Hong Kong Secondary Listing - SourcesYum China is set to raise $2.22 billion in its secondary Hong Kong listing after indicating that its shares would be priced at HK$412 each, according to two sou… Continue Reading
0 comments: